,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast']
#asco22 we are all encouraged to see the results announced of the destiny-breast 04 study. advocates work and look forward to the day when there is a definitive end to #breastcancer #nationalcancersurvivorsday 
Co-Operations Mgr. RVA Career ExpoSpring 2018 #ProjectManagement  #Consulting  #VendorManagement #TrainingandDevelopment